Effective Connectivity of LSD-induced Ego Dissolution
Using dynamic causal modelling of resting‑state fMRI in 25 healthy adults given 100 mg LSD or placebo, the study shows that at peak LSD the normally inhibitory effective connectivity from the salience network to the default mode network becomes excitatory and the inhibitory influence from the default mode to the dorsal attention network is reduced, indicating a diminution of anticorrelation between canonical resting‑state networks. These connectivity changes implicate disruption of the hierarchical balance of intrinsic networks as a neural mechanism of LSD‑induced ego dissolution and link anticorrelation alterations to psychosis and psychedelic therapeutic outcomes.
Authors
- Franz Vollenweider
- Katrin Preller
- Adeel Razi
Published
Abstract
Classic psychedelic-induced ego dissolution involves a shift in the sense of self and blurring of boundary between the self and the world. A similar phenomenon is identified in psychopathology and is associated to the balance of anticorrelated activity between the default mode network (DMN) – which directs attention inwards – and the salience network (SN) – which recruits the dorsal attention network (DAN) to direct attention outward. To test whether change in anticorrelated networks underlie the peak effects of LSD, we applied dynamic causal modeling to infer effective connectivity of resting state functional MRI scans from a study of 25 healthy adults who were administered 100mg of LSD, or placebo. We found that change in inhibitory effective connectivity from the SN to DMN became excitatory, and inhibitory effective connectivity from DMN to DAN decreased under the peak effect of LSD. These changes in connectivity reflect diminution of the anticorrelation between resting state networks that may be a key neural mechanism of LSD-induced ego dissolution. Our findings suggest the hierarchically organised balance of resting state networks is a central feature in the construct of self. Significance The findings can inform the parallel between the maintenance of subject-object boundary and changes to anticorrelated canonical resting state brain networks. Effective connectivity informs the hierarchical organisation of brain networks underlying modes of perception. Moreover, the anticorrelation of brain networks is an important measure of mental function. Understanding the neural mechanisms of anticorrelation change under psychedelics help identify its relationship to psychosis and its association to psychedelic assisted therapeutic outcomes.
Research Summary of 'Effective Connectivity of LSD-induced Ego Dissolution'
Introduction
Classic psychedelics produce prominent alterations of consciousness, notably ego dissolution — a shift or loss in the boundary between self and world — that has been linked to changes in large-scale resting state networks (RSNs). Previous functional MRI studies have shown that the default mode network (DMN), associated with self-referential/narrative processes, and the dorsal attention network (DAN), associated with externally directed attention, are typically anticorrelated; the salience network (SN) is thought to coordinate switching between internal and external attention. Prior work has reported reduced anticorrelation between intrinsic and extrinsic networks under some psychedelics and suggested links between these changes and altered self-experience, but conventional functional connectivity cannot determine the directionality of interactions between networks. Stoliker and colleagues set out to test whether directed (effective) connectivity changes among the DMN, SN and DAN accompany LSD-induced ego dissolution. Using dynamic causal modelling (DCM) applied to resting-state fMRI, the study examined network and region-level effective connectivity at placebo, at the peak effects of LSD (75 minutes post-administration) and at a later timepoint (300 minutes). Ego dissolution was quantified with the Oceanic Boundlessness (OBN) dimension of the 5D-ASC, and the authors hypothesised that effective connectivity changes — particularly between DMN and DAN (subject–object boundary) and between SN and DMN (self-related processes) — would characterise peak LSD effects, while the direction (excitatory or inhibitory) of those changes remained exploratory.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Stoliker, D., Novelli, L., Vollenweider, F. X., Egan, G. F., Preller, K. H., & Razi, A. (2022). Effective Connectivity of LSD-induced Ego Dissolution. https://doi.org/10.1101/2021.12.28.21268391
References (32)
Papers cited by this study that are also in Blossom
Carhart-Harris, R. L. · Current Opinion in Psychiatry (2019)
Carhart-Harris, R. L., Bolstridge, &. M., Day, C. M. J. et al. · Psychopharmacology (2017)
Carhart-Harris, R. L., Friston, K. J. · Brain (2010)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Carhart-Harris, R. L., Leech, R., Erritzoe, D. et al. · Schizophrenia Bulletin (2012)
Rodríguez-Fornells, A., Ribeiro, S., Sanches, R. F. et al. · European Neuropsychopharmacology (2015)
Griffiths, R. R., Johnson, M. W. · Journal of Psychopharmacology (2016)
Ho, J. T., Preller, K. H., Lenggenhager, B. · Neuroscience and Biobehavioral Reviews (2020)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Lebedev, A. V., L€ Ovd En, M., Rosenthal, G. et al. · Human Brain Mapping (2015)
Show all 32 referencesShow fewer
Leptourgos, P., Fortier-Davy, M., Carhart-Harris, R. L. et al. · Schizophrenia Bulletin (2020)
Millière, R. · Frontiers in Human Neuroscience (2017)
Milliere, R., Carhart-Harris, R. L., Roseman, L. et al. · Frontiers in Psychology (2018)
Müller, F., Dolder, P. C., Schmidt, A. et al. · NeuroImage (2018)
Nour, M. R., Carhart-Harris, R. L. · British Journal of Psychiatry (2017)
Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)
Palhano-Fontes, F., Andrade, K. C., Tófoli, L.F. et al. · PLOS ONE (2015)
Preller, K. H., Burt, J. B., Adkinson, B. et al. · eLife (2018)
Preller, K. H., Herdener, M., Pokorny, T. et al. · Current Biology (2017)
Preller, K. H., Pokorny, D., Hock, A. et al. · PNAS (2016)
Preller, K. H., Razi, A., Zeidman, P. et al. · PNAS (2019)
Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)
Ross, S., Bossis, A. P., Guss, J. et al. · Journal of Psychopharmacology (2016)
Safron, A., Juliani, A., Reggente, N. et al. · Neuroscience of Consciousness (2025)
Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)
Stoliker, D., Egan, G. F., Razi, A. · Frontiers in Neuroscience (2022)
Studerus, E., Gamma, A., Vollenweider, F. X. · PLOS ONE (2010)
Swanson, L. R. · Frontiers in Pharmacology (2018)
Vollenweider, F. X., Leenders, K. L., Maguire, P. et al. · Neuropsychopharmacology (1997)
Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)
Yaden, D. B., Griffiths, R. R. · ACS Pharmacology and Translational Science (2020)
Cited By (2)
Papers in Blossom that reference this study
Michael, P., Luke, D., Robinson, O. · Frontiers in Psychology (2023)
Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.